sc14d9c
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4)
OF THE SECURITIES EXCHANGE ACT OF 1934
INTERVOICE, INC.
(Name of Subject Company)
INTERVOICE, INC.
(Name of Person(s) Filing Statement)
Common Stock, no par value
(including associated Preferred Stock Purchase Rights)
(Title of Class of Securities)
461142101
(CUSIP Number of Class of Securities)
Office of the General Counsel
Intervoice, Inc.
17811 Waterview Parkway
Dallas, TX 75252
(972) 454-8708
(Name, Address and Telephone Number of Person Authorized to Receive
Notice and Communications on Behalf of the Person(s) Filing Statement)
David E. Morrison, Esq.
James R. Griffin, Esq.
Fulbright & Jaworski L.L.P.
2200 Ross Avenue
Suite 2800
Dallas, TX 75201
(214) 855-8000
þ |
|
Check the box if the filing relates solely to preliminary communications made before the
commencement of a tender offer. |
To: INTV Worldwide
Subject: Intervoice statement on Convergys 2Q 2008 Financial Results
Earlier today, Convergys (NYSE: CVG) announced earnings for 2Q 2008.
According to Dave Dougherty, Convergys President and CEO, Convergys was able to grow
earnings per share in the second quarter in the face of a challenging economic environment. While
Im pleased with the performance of Information Management and HR Management in the quarter, our
Customer Management results need to be better. We have put in place new leadership and we are
taking decisive action to expand and improve Customer Management revenue and margin trends in the
future. Our recently announced acquisition of Intervoice will help us build a leadership position
in Relationship Management solutions. We remain committed to aligning the companys assets and
capital to our Relationship Management strategy and increasing
shareholder value in the process.
A copy of the news release can be found at www.convergys.com.
Despite recent macroeconomic conditions, Convergys 2Q results are solid. The executive management
and board of directors for both companies remain committed to the pending merger for all the
reasons that were proposed. It is about growth not consolidation and we expect it to create
significant value for our shareholders, new opportunities for our employees, and enhanced ways to
drive our customers success.
Please remember we operate today as separate companies and it is important for all employees to
remain focused on delivering a strong Q2 for Intervoice. We will maintain our commitment to regular
communications, or as new or significant information becomes available. As always, we encourage you
to speak to your manager or HR representative for any additional questions you might have.
Thank you.
|
|
|
|
|
|
Bob Ritchey |
|
Jim Milton |
Important Information
This communication is neither an offer to purchase nor a solicitation of an offer to sell
securities. The tender offer for the outstanding shares of Intervoice common stock has not
commenced. At the time the expected tender offer is commenced, Convergys Corporation intends to
file a tender offer statement on Schedule TO with the Securities and Exchange Commission, and
Intervoice intends to file a solicitation/recommendation statement with respect to the tender
offer. Investors and Intervoice shareholders are strongly advised to read the tender offer
statement (including the offer to purchase, letter of transmittal and other offer documents) and
the related solicitation/recommendation statement because they will contain important information.
When available, the offer to purchase, the related letter of transmittal and certain other offer
documents, as well as the solicitation/recommendation statement, will be available at no charge on
the Securities and Exchange Commissions website at www.sec.gov. In addition, copies of these
documents and other filings containing information about the Company and the transaction can be
obtained by all shareholders of Intervoice, when available, without charge, by directing a request
to Intervoice, Inc., Attention: Corporate Secretary, 17811 Waterview Parkway, Dallas, Texas 75252,
or by telephone at (972) 454-8000 or on Intervoices website, www.intervoice.com.